USP Convention Applies to Import Synthetic Cathinones
Published Date: 3/19/2026
Notice
Summary
The United States Pharmacopeial Convention wants to become an official importer of certain controlled substances like Cathinone and Methcathinone. If you’re a registered manufacturer or interested party, you have until April 20, 2026, to share your thoughts or ask for a hearing. This move could impact how these substances are imported and tracked, but no direct costs are mentioned.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
USP Seeks Importer Registration
On February 11, 2026, the United States Pharmacopeial Convention applied to be registered as an importer of numerous Schedule I and II controlled substances (examples include Cathinone, Methcathinone, lysergic acid diethylamide (LSD), heroin, fentanyl-related substances, methamphetamine, and cocaine). The company says it plans to import those listed substances for distribution as analytical reference standards to its customers for analytical testing of raw materials.
Deadline to Comment or Request Hearing
Registered bulk manufacturers of the affected drug classes and other applicants may submit electronic comments or objections, or file a written request for a hearing, on or before April 20, 2026 via regulations.gov or by mail to DEA addresses listed in the notice. If you are a registered bulk manufacturer or an applicant and want to object or ask for a hearing, you must act by April 20, 2026.
Import Restriction on Finished Dosage Forms
The notice states that any registration approval will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale. Approval will occur only when the registrant's business activity is consistent with 21 U.S.C. 952(a)(2).
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06523 — Designation of P2P Methyl Glycidic Acid as a List I Chemical
Starting May 4, 2026, anyone handling P2P methyl glycidic acid—a key chemical used to make illegal drugs like methamphetamine—must follow new government rules and register with the DEA. This means all transactions, big or small, will be closely watched to stop illegal drug production. Businesses dealing with this chemical should act fast to stay legal and avoid penalties.
2026-06521 — Importer of Controlled Substances Application: Lipomed/LGC Standards
Lipomed/LGC Standards wants to become an official importer of certain controlled substances, like 3-Fluoro-N-methylcathinone. This means companies involved with these drugs can comment or ask for a hearing by May 4, 2026. If approved, it could impact how these substances enter the U.S., but no direct costs are mentioned yet.
2026-06051 — Importer of Controlled Substances Application: Usona Institute
Usona Institute wants to become an official importer of some powerful controlled substances like mescaline and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by April 29, 2026. This move could impact research and medical use, with no direct cost changes announced yet.
2026-05912 — Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
SpecGx LLC wants to become a big-time maker of some powerful and tightly controlled drugs, including things like psilocybin and fentanyl. People and companies already registered can share their thoughts or ask for a hearing by May 26, 2026. This move could shake up how these substances are made and handled, so keep an eye on the deadlines if you’re involved!
2026-05618 — Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
Starting April 22, 2026, the DEA is putting 3-methoxyphencyclidine (3-MeO-PCP) into Schedule I, meaning it’s now officially a highly controlled substance with strict rules. This affects anyone who makes, sells, studies, or even possesses 3-MeO-PCP, who will face serious legal consequences. This move helps the U.S. follow international drug laws and keeps communities safer.
2026-05486 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) just updated which chemical mixes are officially exempt from strict drug rules between September 2024 and December 2025. Companies and labs using these chemicals should check the new list to see if their products are approved or denied. You’ve got until May 19, 2026, to share your thoughts, and no extra fees are involved—just a quick review and comment if you want!
Previous / Next Documents
Previous: 2026-05358 — Bulk Manufacturer of Controlled Substances Application: Siegfried Grafton, Inc.
Siegfried Grafton, Inc. wants to become a big-time maker of some powerful controlled substances, including LSD, marijuana extracts, and psilocybin. People and companies already registered can share their thoughts or ask for a hearing by May 18, 2026. This move could shake up how these substances are produced and handled, with no direct cost changes announced yet.
Next: 2026-05360 — Importer of Controlled Substances Application: Pisgah Laboratories Inc
Pisgah Laboratories Inc wants to become an official importer of certain controlled substances like Phenylacetone and Ecgonine. People and companies involved can share their thoughts or ask for a hearing by April 20, 2026. This move could impact drug manufacturing and import rules, but no direct costs are mentioned yet.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in